Philadelphia University + Thomas Jefferson University
Sidney Kimmel Medical College
Department of Dermatology & Cutaneous Biology

South, Andrew

< Back

Profile

Andrew P South, PhD

Andrew P. South, PhD

Contact Dr. South

Bluemle Life Sciences Building, Room 406
233 South Tenth Street
Philadelphia, PA 19107

(215) 955-1934

Publications

Most Recent Peer-Reviewed Publications

  1. Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico
  2. Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis article
  3. Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell Carcinoma
  4. Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: The identification of mechanisms of differential sensitivity
  5. High concordance between clinical diagnosis of epidermolysis bullosa and immunofluorescence with a small, well-matched antibody panel
  6. First report of COL7A1 mutations in two patients with recessive dystrophic epidermolysis bullosa from Peru
  7. Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration
  8. Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa
  9. Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes
  10. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity
  11. Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers
  12. Cardiomyopathy diagnosed in the eldest child harbouring p.S24X mutation in JUP
  13. MEK Is a Therapeutic and Chemopreventative Target in Squamous Cell Carcinoma
  14. Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma
  15. CREBBP mutation in human cutaneous squamous cell carcinoma
  16. Type VII Collagen Replacement Therapy in Recessive Dystrophic Epidermolysis Bullosa—How Much, How Often?
  17. Exosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma
  18. Lysyl hydroxylase 3 localizes to epidermal basement membrane and is reduced in patients with recessive dystrophic epidermolysis bullosa
  19. Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation
  20. Next-Generation Sequencing for Mutation Detection in Heritable Skin Diseases: The Paradigm of Pseudoxanthoma Elasticum